ASSESSMENT OF COMORBIDITY IN THOSE SUFFERING FROM CHRONIC OBSTRUCTIVE PULMONARY D
https://doi.org/10.21292/2075-1230-2017-95-4-11-14
Abstract
Goal of study: to assess the Charlson comorbidity index in those suffering from chronic obstructive pulmonary disease (COPD).
Materials and methods. 207 patients suffering from COPD smoking for a long period of time (the smoker index of 240 and time of smoking of 40 packs/years were enrolled into the study. SCORE risk charts were used for evaluation of cardiovascular risk. The respiratory function was evaluated by the multi-module unit of MasterLab/Jaeger type. Charlson comorbidity index was used to assess comorbidity.
Results. Charlson comorbidity index made 4.49 ± 1.50 scores in the studied group, those with very high cardiovascular risk made 68.9%. The confident correlation has been found out between total cardiovascular risk and Charlson comorbidity index. Direct moderate correlation has been found out between comorbidity index and rates of packs/years. Confident correlations have been found between comorbidity index and VC (r = -0.39, p < 0.005), comorbidity index and RV (r = 0.46, p < 0.05).
About the Author
E. V. Kochetova
Petrozavodsk State University
Russian Federation
Russian Federation
Russia Candidate of Medical Sciences, Associate Professor of Hospital Therapy Department of Medical Institute,
33, Lenina Ave., Petrozavodsk, Karelia Republic, 185910
References
1. Cardiovascular prevention. National guidelines. Appendix to Kardiovaskulyarnaya Terapiya i Profilaktika Journal, 2011, vol. 10, no. 6, pp. 1-64. (In Russ.)
2. Obrezan А.G., Kukol L.V., Erdneev B.А. Chronic obstructive pulmonary disease and co-morbid cardiovascular disease in elderly and senile patients: problems of diagnostics and treatment. Vestn. SPbGU, 2010, ser. 11, issue 2, pp. 51. (In Russ.)
3. Charlson M.E., Pompei P., Ales K.L. et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis., 1987, vol. 40, pp. 373-383.
4. Conroy R.M., Pyorala K., Fitzgerald A.P. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europa: the SCORE project. Eur. Heart J., 2003, vol. 24, pp. 987-1003.
5. Kanis J.A., Black D., Cooper C. et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporosis Int., 2002, vol. 3, pp. 527-536.
6. Kanis J.A., Gluer C.C. For the Committee of Scientific Advisors, International Osteoporosis Foundation. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int., 2000, vol. 11, pp. 192-202.
7. Kanis J.A., Johnell O., Oden A., Johanson H., McCloskey E. FRAXTM and the assessment of fracture probability in men and women from the UK. Osteoporosis Int., 2008, vol. 19, no. 4, pp. 385-397.
8. Sin D.D., Man S.F. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc. Am. Thorac. Soc., 2005, vol. 2, no. 1, pp. 8-11.
Review
For citations:
Kochetova E.V. ASSESSMENT OF COMORBIDITY IN THOSE SUFFERING FROM CHRONIC OBSTRUCTIVE PULMONARY D. Tuberculosis and Lung Diseases. 2017;95(4):11-14. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-4-11-14
Views:
1095
Email this article 